Data coverage, completeness and provenance for IMAGION BIOSYSTEMS LIMITED in the Stock Market API — Health Care · Diagnostics & Research.
Source date: 2026-10-30T04:34:49. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0050 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0050 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0050 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0050 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0050 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/IBX/prices · Price parameters and adjustment semantics
Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses. It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry. The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Website: https://imagionbiosystems.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2025), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/IBX/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2025 (AUD) | 2025-12-31 | 24 | yfinance | ||||
| FY2024 (AUD) | 2024-12-31 | 27 | yfinance | ||||
| FY2023 (AUD) | 2023-12-31 | 29 | yfinance | ||||
| FY2022 (AUD) | 2022-12-31 | 29 | yfinance | ||||
| FY2021 (AUD) | 2021-12-31 | 5 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/IBX
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/IBX/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/IBX/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/IBX/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/IBX/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/IBX
Free tier — instant API key. Built for AI agents.